eXoZymes, Inc. (EXOZ) Key Metrics
EXOZ valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $38.1M
- Enterprise value
- $54.6M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- —
- Price / book
- 16.2
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- —
EXOZ key metrics, 2021–2025
Fiscal year ended December 31, 2025 · U.S. dollarsEXOZ valuation Price multiples at each fiscal year-end price.
EXOZ returns How much profit the business earns on the capital it uses.
EXOZ per-share figures Results divided by the shares outstanding at year-end.
EXOZ financial health Debt, liquidity and how easily interest is covered.
EXOZ valuation history
EXOZ returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
EXOZ debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
EXOZ price vs earnings per share
EXOZ key metrics
2021–2025| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Valuation | |||||
| Market capitalization | $91.4M | $134.1M | — | — | — |
| Enterprise value | $89.6M | $125.8M | — | — | — |
| Price / book | 26.9 | 12.9 | — | — | — |
| Earnings yield | −10.0% | −4.4% | — | — | — |
| Free cash flow yield | −7.3% | −6.6% | — | — | — |
| Share price at fiscal year-end | $10.90 | $16.50 | — | — | — |
| Per share | |||||
| Revenue per share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Earnings per share | −$1.09 | −$0.72 | −$0.25 | −$0.17 | −$0.15 |
| Operating cash flow per share | −$0.78 | −$1.05 | −$0.15 | −$0.15 | −$0.20 |
| Free cash flow per share | −$0.80 | −$1.10 | −$0.18 | −$0.18 | −$0.25 |
| Cash per share | $0.36 | $1.20 | $0.01 | $0.07 | $0.07 |
| Book value per share | $0.41 | $1.28 | −$0.05 | $0.17 | $0.15 |
| Tangible book value per share | $0.41 | $1.28 | −$0.05 | $0.17 | $0.15 |
| Capex per share | $0.02 | $0.05 | $0.04 | $0.02 | $0.05 |
| Debt per share | $0.15 | $0.17 | $0.20 | $0.07 | $0.09 |
| Shares outstanding | 8.4M | 8.1M | 8.1M | 8.1M | 8.1M |
| Change in shares outstanding | +3.1% | 0.0% | 0.0% | 0.0% | — |
| Returns & profitability | |||||
| Return on equity (ROE) | −132.6% | −116.8% | — | −108.7% | −101.0% |
| Return on invested capital (ROIC) | −416.1% | −288.5% | −109.8% | −75.4% | −74.6% |
| Return on assets (ROA) | −96.4% | −70.6% | −65.3% | −55.5% | −51.5% |
| Return on tangible assets | −153.4% | −45.0% | −57.3% | −52.0% | −51.5% |
| Financial health | |||||
| Total debt | $1.2M | $1.4M | $1.6M | $608,773 | $720,627 |
| Cash & short-term investments | $3.0M | $9.7M | $66,533 | $558,570 | $547,806 |
| Net debt | −$1.8M | −$8.3M | $1.5M | $50,203 | $172,821 |
| Debt / equity | 0.37 | 0.13 | — | 0.44 | 0.60 |
| Debt / assets | 0.21 | 0.11 | 0.45 | 0.23 | 0.31 |
| Current ratio | 2.51 | 8.12 | 0.50 | 2.32 | 2.61 |
| Quick ratio | 2.51 | 8.12 | 0.50 | 2.32 | 2.61 |
| Working capital | $2.4M | $9.5M | −$1.2M | $834,881 | $645,564 |
| Invested capital | $1.6M | $2.1M | $1.2M | $1.4M | $1.4M |
| Tangible asset value | $3.4M | $10.4M | −$384,319 | $1.4M | $1.2M |
| Net current asset value | $1.4M | $8.2M | −$2.7M | $156,113 | −$102,683 |
| Graham net-net per share | $0.10 | $0.94 | −$0.40 | −$0.02 | −$0.03 |
| Capital allocation | |||||
| Capex / depreciation | 0.59 | 1.48 | 1.47 | 1.26 | 7.11 |
| Efficiency | |||||
| Days payables outstanding | — | 1,110.6 | — | 806.7 | 1,642.3 |
| Receivables turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables turnover | — | 0.33 | — | 0.45 | 0.22 |
| Asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average receivables | $627,320 | $809,800 | $845,926 | $638,942 | $468,353 |
| Average payables | $1.1M | $813,582 | $544,354 | $326,546 | $267,296 |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from EXOZ's annual financial statements (latest annual report filed March 30, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
EXOZ valuation and financial ratios
eXoZymes earned a return on equity of −132.6% and a return on invested capital of −416.1% in fiscal 2025. It ended the year with $1.2 million of debt and $3.0 million in cash and short-term investments, a net cash position of $1.8 million. The share count rose 3.1% from 8.1M to 8.4M over 4 years.
See the EXOZ income statement, the EXOZ chart for price history, or the EXOZ stock overview for the latest quote and news.
EXOZ key metrics FAQ
What is eXoZymes's return on equity?
eXoZymes's return on equity (ROE) was −132.6% in fiscal 2025: net income of -$9.2 million on average shareholders' equity of $6.9 million.
What is eXoZymes's ROIC?
eXoZymes's return on invested capital was −416.1% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does eXoZymes have?
eXoZymes had total debt of $1.2 million at the end of fiscal 2025, a debt-to-equity ratio of 0.37 and more cash than debt.
What is eXoZymes's free cash flow yield?
eXoZymes generated -$6.7 million of free cash flow in fiscal 2025, a free cash flow yield of −7.3% on its market value at year-end ($91.4 million).
What is eXoZymes's current ratio?
eXoZymes's current ratio was 2.51 at the end of fiscal 2025: current assets were 2.51 times current liabilities.